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Dorsal Root Ganglion Stimulation Lead Fracture Within 
the Superficial Fascial Layers in 4 Cases
Kenneth B. Chapman, MD,*†‡ Kiran V. Patel, MD,*‡ Noud van Helmond, MD,*§  
and George C. Chang Chien, DO∥¶      
We present 4 cases of dorsal root ganglion stimulation lead fracture. In these cases, the surgi-
cal technique involved (1) traversing fascial layers for placement of leads via a Tuohy needle in 
the upper low back, (2) subcutaneous tunneling from the implantable pulse generator site to 
the lead puncture site without dissecting below the superficial fascial plane at the puncture site, 
and (3) connection of the lead/extension with the generator. All fractures occurred adjacent to 
the original lead puncture site. These cases suggest lead entrapment within the membranous 
fascial plane, with tension on a thin lead, is a mechanism underlying lead fracture. (A&A 
Practice. 2020;14:e01307.)
GLOSSARY
DAT = deep adipose tissue; DRG-S = dorsal root ganglion stimulation; HIPAA = Health Insurance 
Portability and Accountability Act; IPG = implantable pulse generator; ODI = Oswestry Disability 
Index; SAP = superior articular process; SAT = superficial adipose tissue; SCS = spinal cord stimu-
lation; TLF = thoracolumbar fascia; VAS = visual analog pain scale
Dorsal root ganglion stimulation (DRG-S) is a type of neuromodulation which has been shown to be effective in the treatment of complex regional 
pain syndrome and is showing promise in the treatment 
of low back pain as well as other pain syndromes.1–3 
DRG-S system placement involves placing a lead over 
the DRG. The DRG-S lead is smaller in size compared to 
traditional spinal cord stimulation (SCS) leads; relative to 
SCS leads, DRG-S leads are 30% thinner (1.2 vs 0.9 mm 
in diameter). DRG-S has been found to be a safe and effi-
cacious treatment; however, as with SCS, lead migration 
and lead fracture have been highlighted as potential com-
plications.4,5 Lead fracture typically presents with loss of 
stimulation and readings of high impedance or “malfunc-
tion of lead” on the DRG-S system programmer. Lead 
fracture or disconnection is confirmed through imaging 
of the lead or checking lead impedances.5,6 We present 4 
cases of lead fracture after DRG-S placement (Proclaim, 
Abbott, Chicago, IL). In these cases, the surgical tech-
nique involved (1) traversing the superficial and deep 
fascial layers for epidural placement of the DRG-S lead 
via a Tuohy needle in the upper low back, (2) subcutane-
ous burial of the implantable pulse generator (IPG) in the 
gluteal region, (3) subcutaneous tunneling from the IPG 
site to the lead puncture site without dissecting below the 
superficial fascial plane at the puncture site, and finally, 
(4) connection of the lead/extension with the IPG, as 
described in the literature.7,8
In these cases, the fractures were visible on fluoroscopy 
and found to be superficial, adjacent to the original lead 
puncture site at the skin. We describe a putative mechanism 
causing the fractures, as well as alterations to the surgi-
cal procedure, to mitigate similar events in the future. All 
patients described in this report provided Health Insurance 
Portability and Accountability Act (HIPAA) authorization 
and written informed consent for the publication of their 
case. The following descriptions describe the course of the 
cases at long-term follow-up after implantation. Each patient 
initially underwent a DRG-S trial and experienced >50% 
relief on the visual analog pain scale (VAS) with concomitant 
improvements in function before permanent implantation.
CASE DESCRIPTION NUMBER 1
The first case is a 46-year-old man with a history of L5-S1 
laminectomy and discectomy with persistent low back 
and right leg pain who had DRG-S leads implanted at 
the bilateral T12 and right S1 levels.7 His VAS pain score 
improved from a baseline of 90/100 to 35/100 mm, and 
his Oswestry Disability Index (ODI) from 78 (crippled) to 
28 (moderate disability). He continued to do well until 14 
months postimplantation when his low back pain wors-
ened. On interrogation of the DRG-S system with the pro-
grammer, his right T12 DRG-S lead demonstrated high 
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impedance (>7000 Ω). The patient denied any events, 
such as trauma or falls, that might have affected the lead. 
A fluoroscopic image was obtained and identified a lead 
fracture. The location of the fracture was consistent with 
the original lead puncture site at the skin (Figure 1). The 
patient has since had his lead surgically revised and 
experienced subsequent restoration of pain relief from 
DRG-S therapy.
CASE DESCRIPTION NUMBER 2
The second case is a 35-year-old woman with chronic vagi-
nal and pelvic pain secondary to endometriosis, interstitial 
cystitis, and pelvic floor dysfunction who had DRG-S leads 
implanted at the bilateral L1 and S2 levels. With DRG-S, her 
VAS pain improved from 90/100 to 10/100 mm, and her 
modified ODI changed from 71 (crippled) to 13 (minimal 
disability). She continued to do well until 13 months post-
implantation when after a fall, she experienced a partial 
return of her pain. On interrogation of her DRG-S system, 
her left L1 lead demonstrated high impedance (>7000 Ω). A 
visible lead fracture was noted on her lumbar X-ray, which 
was consistent with the location of the superficial skin inci-
sion (Figure 2A). The patient subsequently underwent lead 
revision, with a restoration of pain coverage by the DRG-S 
therapy.
CASE DESCRIPTION NUMBER 3
The third case is a 66-year-old woman with chronic pelvic 
pain who failed multiple interventional procedures and had 
a previous high-frequency SCS system that lost efficacy. She 
had DRG-S leads implanted at the bilateral L1 and S2 lev-
els. After implantation, her pain improved from 90/100 to 
30/100 mm on VAS, and her modified ODI improved from 55 
to 18. She returned 18 months after implantation with worsen-
ing bilateral groin and labial pain. Interrogation of the DRG-S 
system revealed her bilateral L1 leads had an impedance of 
>7000 Ω, and a fluoroscopic image identified bilateral L1 lead 
fractures close to where the lead originally had punctured the 
skin (Figure 2B). She underwent surgical revision and had a 
restoration of the effectiveness of DRG-S therapy.
CASE DESCRIPTION NUMBER 4
The fourth case is a 78-year-old man with chronic low back 
pain and left-sided radicular pain who failed multiple inter-
ventional procedures and was deemed a poor surgical can-
didate by his surgeon. He had DRG-S leads implanted at the 
bilateral T12 DRGs for his low back pain and a left S1 lead 
for his left leg pain. After implantation, his pain improved 
from 85/100 to 30/100 mm on VAS, and his ODI improved 
from 68 to 18. He returned 13 months after implantation 
with worsening left-sided low back pain. Interrogation of the 
Figure 1.  Lead fracture visible on fluoroscopy occurring at the region where skin puncture with the lead and the tunneled epidural catheter 
technique were performed. A 2-mm puncture site was used for the tunneling, without anchoring the lead. The needle tip location was consis-
tent with the fracture site under fluoroscopy.
Figure 2.  Visualized lead fractures demonstrated on fluoroscopy. A, 
A visible lead fracture of a right  L1 lead. B, Visible lead fractures at 
the bilateral L1 DRG-S leads. C and D, Anteroposterior and lateral 
fluoroscopic views of lead fracture occurring in a superficial plane at 
the Tuohy needle entry point. The separation of the internal electri-
cal components was visualized in all leads and all leads had intact 
outer lead sheaths at the time of revision. DRG-S indicates dorsal 
root ganglion stimulation.
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DRG-S system revealed his left T12 lead had an impedance 
of >7000 Ω, and a fluoroscopic image identified a lead frac-
ture close to where the lead likely originally had punctured 
the skin (Figure 2C, D). He underwent surgical revision and 
had a restoration of the effectiveness of DRG-S therapy.
DISCUSSION
We described 4 cases of visible DRG-S lead fracture, which 
occurred adjacent to the puncture site at the skin. After 
DRG-S lead placement, the lead exits the epidural space 
and sequentially passes through the spinal ligaments, the 
erector spinae muscles, the deep thoracolumbar fascia 
(TLF), the deep adipose tissue (DAT), the membranous 
plane, superficial adipose tissue (SAT), and the skin. The 
membranous plane was previously referred to as the super-
ficial, Scarpa’s, Camper’s, or Colle’s fascia. The subcutane-
ous tissue has since been renamed to the DAT and the SAT, 
separated by a membranous plane. This membranous plane 
surrounds the body, whereas the second layer, the deep fas-
cia, surrounds the musculoskeletal system and separates it 
into fascial compartments.9–12 Together, the TLF, DAT, mem-
branous plane, and SAT create a sliding system between 
the skin and the muscles, allowing changes in external and 
internal stimuli and muscular activity to be disconnected 
from direct transmission between the muscles and the 
skin.10 Fascial planes can respond to sensory input by con-
tracting; by relaxing; or by adding, reducing, or changing 
their composition through fascial remodeling.13 In response 
to physiologic stress or injury, fibroblasts secrete collagen 
and other proteins making the fascia’s composition thicker 
and less extensible. These changes potentiate the fascia’s 
tensile strength but may cause restriction of elements pass-
ing through the fascia. In the case of DRG-S leads passing 
through the fascia, such changes may potentially anchor the 
lead at this point.
In our 4 cases, lead fractures occurred superficially, well 
above the deep fascial layer. The tunneled epidural implant 
technique we used involves standard DRG-S lead place-
ment with an “S” tension loop (Figure 3A), and then driving 
a Tuohy needle from the IPG pocket, traversing the DAT, 
through the membranous layer, and through the SAT to 
the paramedian skin puncture site (Figure 3B).7 Thus, in its 
final position, the lead passes from the pocket through the 
DAT, and as it nears the puncture site, it passes through the 
membranous plane, and then dips back down into the DAT 
and TLF to the epidural space, causing a small section of the 
lead to be trapped above the membranous plane in the SAP 
(Figure  3C). This relatively acute bend may cause a focal 
area of tension and entrapment of the lead, potentially lead-
ing to friction and localized tension within the thin lead. In 
the cases we described, there was a clear separation of the 
fractured leads, indicating that the underlying wiring had 
separated, whereas, on explant, the lead casings were still 
intact. A similar phenomenon can be seen in focal nerve 
entrapments syndromes, as nerves traverse muscle, inter-
muscular septa, and fascia planes. This multiplanar course 
can cause an “internal stretch lesion” due to stress and ten-
sion on the nerve.14 These types of injuries are often difficult 
to diagnose and can explain why traditional nerve release 
procedures may be inadequate in treating focal nerve inju-
ries and require dissection of the fascia layers.15
The tunneled epidural catheter technique, with or with-
out a superficial stab incision at the skin, creates less tissue 
trauma, requires less suturing, and may potentially decrease 
infection risk. However, because of the potential risk of lead 
fracture, we have modified our implantation technique 
to abandon the approach above. As was demonstrated in 
these 4 cases, we believe the transection of membranous, or 
Figure 3.  Previously used DRG-S lead placement approach. A, Planes of subcutaneous tissue with the Tuohy needle and lead placed. B, 
Tunneled epidural catheter technique for tunneling the lead to the pocket. Note the transection of the membranous layer. C, The lead is pulled 
between the membranous plane, potentially causing friction and focal areas of tension, ultimately damaging the lead.
Figure 4.  Passing the tunneling 
device deep to the membranous 
layer may avoid entrapment 
within the fascial plane.
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superficial fascial, plane can potentially contribute to lead 
fracture. Our updated implant technique utilizes an incision 
and anchoring of leads deep to the membranous plane, at all 
thoracolumbar levels. When passing the tunneling device, 
it should be performed toward the IPG pocket, as passing 
from the pocket to a smaller, superficial incision may still 
result in the lead crossing through the membranous plane. 
See Figure 4 for an ideal lead position.
Lead fracture occurring in DRG-S not only results in loss 
of pain relief, but also leads to revision, replacement, or 
explantation of the device. Revision of DRG-S leads can be 
challenging technically, given the possible presence of adhe-
sions, which increases the risk of further complications.
LIMITATIONS
Our study design is limited by the fact that we are only 
describing 4 cases with limited long-term follow-up. Large 
prospective studies with long-term follow-up, in vivo 
dynamic biomechanics analyses, and real-world registry 
data could be helpful to elucidate the robustness of the 
proposed anchoring technique in mitigating future lead 
fracture risks. Our leads were all at the upper lumbar/
lower thoracic region, and a larger pool of subjects could 
identify if the distance to the generator pocket plays a role. 
Additionally, DRG-S was used off-label in the present cases, 
since the only approved indication in the United States is 
complex regional pain syndrome. However, off-label use 
of DRG-S is common,16 and retrospective series have spe-
cifically described the use of DRG-S for low back pain1 and 
pelvic pain.17
CONCLUSIONS
We described 4 cases of DRG-S lead fracture that we believe 
to be partially related to the technical component of the 
implant, which resulted in short lead sections experiencing 
tension due to fascial plane contraction. These cases suggest 
entrapment within the membranous plane of a thin DRG-S 
lead may be one of the potential causes for lead fracture, 
and thus, modification of the DRG-S implant technique 
should be considered to avoid interactions of the lead and 
this plane. Ongoing longitudinal surveillance of complica-
tions with DRG-S systems may help corroborate our obser-
vations. E
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